Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: High metallothionein predicts poor survival in glioblastoma multiforme

Fig. 5

a MTs mean expression in short, intermediate (Int) and long survival GBM patients. M1E, Mt1F, MT1H, MT1M, MT1X, MT2A and MT3 mean expression intensity is higher in short survival patients compared to long survival patients. b Kaplan–Meier survival curve for MT2A expression. Red line- up regulated MT2A; green line- down regulated MT2A; black line - intermediate expression. c HIPK2 mean expression intensity and survival in GBM samples. HIPK2 Affymetrix probes (213763_at in red and 219028_at in blue). HIPK2 is higher in high survival patients compared to low survival patients in both probe sets. d Kaplan–Meier survival curve for HIPK2 expression. Red line- up regulated HIPK2; green line- down regulated HIPK2; black line- intermediate expression

Back to article page